current CDC Guidelines

I. Detailing
​Materials & Resources ​

Detailing campaign materials, provider resources, and patient-facing materials.​

II. Best Practices from Our AD Community

Blogs, presentations, and webinars on substance use.
​​​

III. General Opioid Safety
​Overviews & Guidelines​ ​

Guides, materials, and toolkits from federal agencies to inform your detailing project. 

IV. Opioid Safety
Articles & Publications​​

Research articles on opioid safety, substance use, and harm reduction. ​​​​

​I. DETAILING MATERIALS & RESOURCES

Examples of AD Campaign Materials:

• Training Detailing Aid: Reducing Stigma, Saving Lives: How Clinicians Can Help Patients Who Use Substances | NaRCAD
• Training Detailing Aid: Improving Patient Safety and Reducing Opioid Overdoses | NaRCAD
• Modules: Clinical Modules & Corresponding Detail Aids | Alosa Health
• Detailing Binder: Opioid Stewardship and Chronic Pain: A Guide for Primary Care Providers | San Francisco Department of Public Health
• Academic Detailing Kit: Care for People Who Use Substances | Arizona State University, Southwest Interdisciplinary Research Center, DISH-AZ
• Toolkit: Creating and Implementing an Academic Detailing (AD) Program | University of Illinois Chicago
• Resource: Opioid Overdose Education & Naloxone Distribution (OEND) | VA Academic Detailing Service​
• Toolkit: Buprenorphine Action Kit (2019) | NYC Department of Health and Mental Hygiene
• Resource: Pain & Opioid Safety Initiative (OSI) Materials | VA Academic Detailing Service
• Toolkit: Naloxone for Pharmacists Action Kit (2018) | NYC Department of Health and Mental Hygiene
• Provider Brochure: Managing Chronic Non-Cancer Pain | San Francisco Department of Public Health
• Toolkit: Cocaine Action Kit (2020) | NYC Department of Health and Mental Hygiene​
• Resource: Opioid Safety Educational Materials | Center for Innovative Academic Detailing on Opioids & Stimulants (CIAO). San Francisco Department of Public Health
• Scheduling Visits: Opioid AD 1-Pager Example | Mountain Area Health Education Center

Clinician-Facing Resources:

• Resource: Healthcare Professionals | CDC
• Resource: Training Modules: Overdose Prevention Trainings for Patient-Centered Care | CDC
• Conversation Starter: Empathy: Talking to Patients About Substance Use Disorder | CDC
• Resource: Overdose Graphics and Videos | CDC
• Toolkit: Trainer's Toolkit for Safer and Competent Prescribing Education | SCOPE of Pain
• Discussion Guide: Difficult Conversations on Opioids | Minnesota Department of Human Services
• Resource: Healthcare Provider Toolkit​​ | Take Charge Ohio​
• Resource: Nonopioid Pharmacologic Treatments for Chronic Pain | Agency for Healthcare Research and Quality
• Resource: Noninvasive Nonpharmacological Treatments for Chronic Pain | Agency for Healthcare Research and Quality
• Resource: Opioid Treatments for Chronic Pain | Agency for Healthcare Research and Quality
• Resource: Medications for Opioid Overdose, Withdrawal, & Addiction | NIH National Institute on Drug Abuse
• Discussion Guide: Long Term Opioid Therapy | Minnesota Department of Human Services
• Discussion Guide: Tapering Opioids | Minnesota Department of Human Services​
• Dental Health Resource: Opioids & Dental Pain | National Institute of Dental and Craniofacial Research
• Harm Reduction Resource: National Harm Reduction Coalition Resource Center | National Harm Reduction Coalition
• Harm Reduction Resource: Harm Reduction & Child Safety | National Center on Substance Abuse and Child Welfare

 
Patient-Facing Resources:

• Resource: Opioid Therapy and Different Types of Pain | CDC
• Patient Brochure: Opioid Safety and How to Use Naloxone | San Francisco Department of Public Health
• Family Support Resource: Resources for Families Coping with Mental and Substance Use Disorders | SAMHSA
• Resource: Opioid and Medication Safe Storage and Disposal | American Academy of Family Physicians
• Resource: Controlled Substance Public Disposal Location Searcher | US Department of Justice
• Interactive Map: Find Harm Reduction Near You | National Harm Reduction Coalition
• Online Training: Free Naloxone Administration Training | GetNaloxoneNow
• Patient-Facing Video: How to Know if You are Witnessing an Opioid Emergency | NARCAN
• Community Education and Harm Reduction Resources: Prepare Your Community With Narcan | NARCAN
• Example Flyer: End the Stigma of Opioid Use Disorder | Sacramento County Opioid Coalition
  
  

II. BEST PRACTICES FROM OUR AD COMMUNITY

• Model Detailing Visit: Medications for Opioid Use Disorder | NaRCAD
• Model Detailing Visit: Harm Reduction | NaRCAD
• Blog Articles: DETAILS Blog - Opioid Safety | NaRCAD
  • Amplifying the Patient Voice: Strengthening Capacity for Harm Reduction | Adriane Apicelli, MSW, University of New Hampshire
  • A Patient Perspective: Sharing a Story of Drug Use & Recovery | Lindsey C. Beardsley, Individual in Recovery
  • Switching Lenses: A Focus on Harm Reduction for Patients Who Use Substances | Meghan Breckling, PharmD, BCACP, University of Arkansas for Medical Sciences
  • The Importance of Empathy: Understanding the Complexities of Harm Reduction | Shuchin Shukla, MD, MPH, NaRCAD Training Facilitator
  • Beyond Primary Care: Including Dentists in the Conversation on Opioid Safety | Adrienne Butterwick, MPH, CHES, Comagine Health​​​​
• Presentation (begins at 1 hour and 46 minutes): Harm Reduction Academic Detailing: Incorporating Lived Experience into the Development of Key Messages | Maggie Kaufmann, MPH, MA, University of Illinois at Chicago
• Presentation (begins at 1 hour and 57 minutes): To Infinity and Beyond: Detailing Nationwide to ADVANCE Opioid Safety | Nerissa Caballes, PharmD, MS, CRC, Illinois ADVANCE
• Presentation (begins at 3 hours and 13 minutes): The Intersection of HIV, Hepatitis C, and Drug Use: Collaborating with State Partners to Improve Outcomes | Darla Peterson, Iowa DHHS
• Presentation (begins at 3 hours and 33 minutes): AD Harm Reduction for People Who Use Drugs | Katarina Frank, MD, PhD, Alosa Health
• Presentation (begins at 57 minutes): Outreach Beyond Primary Care: Educating Dentists on Opioid Safety in Utah | Adrienne Butterwick, MPH, CHES, Comagine Health
  • Additional Resource: 
    • Dental Prescribing Guidelines
• Presentation (begins at 5 minutes): Preventing Overdose: Helping Clinicians Better Support Patients at Risk | Connie Kitchens, PhD, State of Utah Department of Commerce Division of Professional Licensing
• Presentation (begins at 1 hour and 15 minutes): Impact of Implementing an AD Program on Opioid-Benzodiazepine Co-Prescribing Trends | Mark Bounthavong, PharmD, MPH, VA Academic Detailing Service
• Presentation (begins at 2 hours and 21 minutes): AD in Community Pharmacies: Experiences from a Naloxone, Buprenorphine, and Syringe Safety Intervention | Adriane Irwin, MS, PharmD, BCACP, CDE, Oregon State University College of Pharmacy
• Presentation (begins at 3 hours and 7 minutes): Training Pharmacy Students at Three Wisconsin Schools of Pharmacy in Naloxone-focused AD | Jordan Wulz, PharmD, MPH, BC-ADM, Concordia University Wisconsin
• Presentation (begins at the start of recording): Using Academic Detailing to Improve Maternal and Neonatal Health Through Safer Opioid Prescribing | Traci Green, PhD, MSc, Center of Biomedical Research Excellence (COBRE), Rhode Island Hospital
• Presentation (begins at the start of recording): Identification of Barriers to Opioid Prescribing through AD | Christopher Saffore, PharmD, PhD, University of Illinois at Chicago​
• Webinar: Opioid Use Disorder: Understanding Clinician Stigma to Encourage Behavior Change | NaRCAD
• Webinar: Acute and Chronic Pain Management: Educating Clinicians on the Impact and History of the Opioid Crisis | NaRCAD

III. GENERAL OPIOID SAFETY OVERVIEWS & GUIDELINES

Centers for Disease Control and Prevention (CDC) & Substance Abuse and Mental Health Services Administration (SAMHSA) Guides & Resources:

• Guide: Academic Detailing to Enhance Overdose Prevention: An Implementation Guide for Organizations | CDC​
• Guideline: CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 | CDC
• Toolkit: Opioid Overdose Prevention Toolkit | SAMHSA
• Resource: CDC Overdose Prevention Evaluation Profile for Academic Detailing | CDC​​
• Toolkit: Overdose Prevention | CDC
• Toolkit: 2022 Clinical Practice Guideline Partner Toolkit | CDC
• Toolkit: Naloxone Toolkit | CDC
• Toolkit: Addiction Medicine | CDC​
• Framework: Harm Reduction | SAMHSA

IV. OPIOID SAFETY ARTICLES & PUBLICATIONS

• Archives: JAMA Opioid Research Archives | JAMA Network
• Archives: Overdose Prevention Journal Articles | CDC
• ​Resource: Identifying the Root Causes of Drug Overdose Health Inequities and Related Social Determinants of Health: A Literature Review | NACCHO
• Resource: The Opioid Crisis and the Black/African American Population: An Urgent Issue | SAMHSA
• Archives: AD Literature Archives | NaRCAD
  • Publication: Overdose, Behavioral Health Services, and Medications for Opioid Use Disorder After a Nonfatal Overdose | Christopher M. Jones, PharmD, DrPH, Carla Shoff, PhD, Carlos Blanco, MD, PhD, et al., JAMA Network (June 2024)
  • Publication: ​Pharmacist-driven Deprescribing Initiative in Primary Care | Emily Rea, PharmD, David Portman, PharmD, BCPS, Kara Ioannou, PharmD, Brandi Lumley, PharmD, BCPS, Journal of the American Pharmacists Association (Jan-Feb 2024)
  • Publication: Readiness of Community Pharmacies to Implement an Opioid Safety Intervention | Anthony S. Floyd, PhD, Joseph Silcox, MA, Emily Cousin, PharmD, Adriane N Irwin, MS, PharmD, et al., Journal of the American Pharmacists Association (Jan-Feb 2023)
  • Publication: The Feasibility of Academic Detailing for Acute Oral Pain Management in Outpatient Dentistry: A Pilot Study | Ashley M. Hughes, PhD, MS, Erica Lin, PharmD BCACP, Raza A. Hussain, BDS, DMD, FACS, Gretchen Gibson, DDS, MPH, et al., Journal of the American Pharmacists Association (Jan-Feb 2023)
  • Publication: Implementation of an Academic Detailing Intervention to Increase Naloxone Distribution and Foster Engagement in Harm Reduction from the Community Clinician | Adriane N Irwin, MS, PharmD, Jeffrey Bratberg, PharmD, Zain Al-Jammali, PharmD, Jenny Arnold, PharmD, et al., Journal of the American Pharmacists Association (Jan-Feb 2023)
  • Publication: Decreased Antimicrobial Prescribing Rate Following Academic Detailing of Resident Physicians in Outpatient Clinic | Shannon L. Andrews, MD, Amy A. Gravely, MA, Amanda Beaudoin, DVM, PhD, Meghan K. Rothenberger, MD, et al., Antimicrobial Stewardship & Healthcare Epidemiology (March 2023)
  • Publication: Can Academic Detailing Reduce Opioid Prescriptions in Chronic Non-cancer Pain? | Ketil Arne Espnes, Toruun Hatlen Nøst, Marte Handal, et al.,  BioMed Central Primary Care (March 2023)
  • Publication: A Realist Synthesis of Educational Outreach Visiting and Integrated Academic Detailing to Influence Prescribing in Ambulatory Care: Why Relationships and Dialogue Matter | Karen Luetsch, PhD, Geoff Wong, MA, MBBS, MD(Res), FHEA, FRCGP, Debra Rowett BPharm, Adv Prac Pharm, FPS, BMJ Quality & Safety (May 2023)
  • Publication: Effects of an Academic Detailing Service on Benzodiazepine Prescribing Patterns in Primary Care | Meagan Lacroix, MPH, Fred Abdelmalek, Karl Everett, PhD, Lena Salach, MA, Lindsay Bevan, MS, et al., PLOS ONE (July 2023)
  • Publication: Co-occurring Implementation Strategies: The Effects of Academic Detailing for Opioid Use Disorder Campaign on the Advancing Pharmacological Treatments for Opioid Use Disorder (ADaPT-OUD) Study | Wendy A. Miller, Adam J. Gordo, MD MPH FACP DFASAM, Barbara A. Clothier, Princess E. Ackland, PhD, LP, MSPH, et al., Implementation Research and Practice (September 2023)
  • Publication: Academic Detailing to Improve Appropriate Opioid Prescribing: A Mixed-Methods Process Evaluation | Natasha Kithulegoda, MPH, PhD, Cherry Chu, MSc, Mina Tadrous, PharmD, MS, PhD, Tupper Bean, MHSc, MBA, et al., CMAJ Open (October 2023)
  • Publication: Feasibility and Acceptability of Virtual Academic Detailing on Opioid Prescribing | Mary H. Smart, PharmD, Monika Rao Mandava, Todd A. Lee, PharmD, PhD, A. Simon Pickard, PhD, International Journal of Medical Informatics (December 2020)
  • Publication: Improving the Delivery of Chronic Opioid Therapy Among People Living With Human Immunodeficiency Virus: A Cluster Randomized Clinical Trial | Jeffrey H. Samet, MD, MA, MPH, Judith I. Tsui, MD, MPH, Debbie M. Cheng, ScD, Jane M. Liebschutz, MD, MPH, FACP, et al., Clinical Infectious Diseases (July 2020)
  • Publication: Effect of Academic Detailing on Promoting Appropriate Prescribing of Antipsychotic Medication in Nursing Homes | Mina Tadrous, PharmD, MS, PhD, Kinwah Fung, MSc, Laura Desveaux, PhD, Tara Gomes, PhD, et al., JAMA Network Open (May 2020)
• Publication: Physician Reluctance to Intervene in Addiction: A Systematic Review | Melinda Campopiano von Klimo, MD, Laura Nolan, Michelle Corbin, MBA, et al., JAMA Network Open (July 2024)
• Publication: Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder | Sarah E. Wakeman, MD, Marc R. Larochelle, MD, MPH, Omid Ameli, MD, MPH, et al., JAMA Network (Feb. 2020)
• Publication: From the CDC: The Prevention for States Program: Preventing Opioid Overdose Through Evidence-Based Intervention and Innovation | Amber B. Robinson, Aleta Christensen, Sarah Bacon, PhD, Journal of Safety Research (Feb. 2019)
• Publication: Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial | Erin E. Krebs, MD, MPH, Amy Gravely, MA, Sean Nugent, et al., JAMA Network (March 2018)

ad core toolkits

Explore our other NaRCAD toolkits and find resources you need to build your program.

---

Looking for more resources?

​Contact us to request materials support: